Del Rosso, James
Baldwin, Hilary
Bhatia, Neal
Chavda, Rajeev
York, Jean Phillipe
Harper, Julie
Hougeir, Firas George
Jackson, J. Mark
Noor, Omar
Rodriguez, David A.
Schlesinger, Todd
Weiss, Jonathan
Funding for this research was provided by:
Galderma
Article History
Received: 12 October 2023
Accepted: 12 December 2023
First Online: 9 January 2024
Declarations
:
: All panel members received honoraria from Galderma for participating in this project. James Del Rosso has served as a research investigator, consultant and/or speaker for Almirall, Bausch Health (Ortho Dermatology), BiopharmX, Dermata, Dr. Reddy, EPI Health, Evommune, Ferndale, Galderma, JEM Health, LaRoche Posay, LEO Pharma, L’Oréal, Mayne Pharma, Primus, Sente, Sol–Gel, Sonoma, Sun Pharma, and Vyne Therapeutics (Foamix). Hilary Baldwin has acted as an investigator, consultant, and/or speaker for Almirall, Bausch Health, Cassiopeia, EPI Health, Galderma, La Roche-Posay, L’Oréal, Mayne Pharma, Sol–Gel, Sun Pharma, and Vyne. Neal Bhatia has served as advisor, consultant, and/or investigator for Abbvie, Almirall, Arcutis, Arena, Biofrontera, BMS, BI, Brickell, Dermavant, EPI Health, Ferndale, Galderma, Genentech, InCyte, ISDIN, J&J, LaRoche-Posay, Leo, Lilly, Mayne, Novartis, Ortho, Pfizer, P&G, Regeneron, Sanofi, Stemline, SunPharma, Verrica, and Vyne. Rajeev Chavda and Jean Phillipe York are employees of Galderma. Julie Harper has received honoraria from Almirall, Bausch Health (Ortho Dermatologics), BiopharmX, Cassiopeia, Cutanea, Dermira, EPI Health, Galderma, LaRoche Posay, SolGel, Sun Pharma, and Vyne Therapeutics (Foamix). Firas George Hougeir has served as an investigator, consultant, advisor and/or speaker for Galderma, Abbvie, Aclaris, Almirall, Amgen, Arcutis, Dermavant, Intraderm, ISDIN, Janssen, LEO Pharma, Lilly, Menarini, Novartis, Orthodermatologics, Pfizer, Promius, Regeneron, Sanofi-Genzyme, UCB, and Verrica. J. Mark Jackson has received research, honoraria, and/or consulting support from Abbvie, Arcuitis, BMS, Dermavant, Evommune, Galderma, Janssen, Lilly, Novartis, Pfizer, Sanofi/Genzyme, and UCB. Omar Noor has worked as a consultant for Abbvie Inc., Almirall LLC, Amgen Inc., Galderma, Lilly USA, Ortho Dermatologics, Novartis Pharmaceuticals Corporation, Pfizer Inc., Procter & Gamble Ventures, Regeneron Pharmaceuticals Inc., and Sanofi Genzyme. David Rodriguez has received honoraria, has consultancy agreements with, and/or has served as a speaker for Allergan, Inc, Galderma, Genentech, LEO Pharma, and Merz. Todd Schlesinger has acted in a consulting, speaking or advisory capacity for AbbVie, Allergan, Almirall, Amgen, ASLAN Pharma, Arcutis, Biofrontera AG, Bristol Myers Squibb, Castle Biosciences, Cara Therapeutics, Celgene, CMS Aesthetics DCME, Concert Pharmaceuticals (now SUN), Lilly, Galderma, Genentech, Greenway Therapeutix (shareholder), Janssen, Kintor, MED Learning Group, Merz, MJH Associates, Nextphase Therapeutics, Novartis, Ortho Dermatologics, Pfizer, Pierre Fabre, Plasmed, Prolacta Bioscience, RBC, Regeneron, Sanofi Genzyme, SkinCeuticals/L’Oréal, Sisaf, SUN Pharma, UCB and Verrica. Jonathan Weiss has acted as an investigator/advisor and/or speaker for Almirall, Dr Reddy’s, EPI Health, Foamix, Galderma, Novartis, and Ortho Derm.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. The patient presented in the case study has consented to their anonymized medical details, treatment plan, and patient photos to be published.